Diethyl Hydrogen Phosphate

Diethyl Hydrogen Phosphate

SCHEMBL8410487

CCOP(=O)(O)OCC.N=C(N)S

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.40
PPARD Q03181 2/20 0.40
TP53 P04637 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
ALOX15 P16050 1/20 0.32
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31
LPAR1 Q92633 2/20 0.30
LPAR3 Q9UBY5 2/20 0.30
LPAR2 Q9HBW0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diethyl Hydrogen Phosphate SCHEMBL28772823 0.87 NOS3 (0.52) TSHRPPARDTDP1
Diethyl Hydrogen Phosphate SCHEMBL27873282 0.83 PPARD (0.38) TSHRPPARDTP53TDP1ALOX15
Diethyl Hydrogen Phosphate SCHEMBL93056 0.83
Diethyl Hydrogen Phosphate SCHEMBL27294237 0.83 TSHR (0.56) TSHRPPARDTP53TDP1CA12
Diethyl Hydrogen Phosphate SCHEMBL11752938 0.80 TSHR (0.53) TSHRPPARDTP53TDP1CA12
Diethyl Hydrogen Phosphate SCHEMBL906759 0.80 TSHR (0.53) TSHRPPARDTP53TDP1CA12
Diethyl Hydrogen Phosphate SCHEMBL11757040 0.80 TSHR (0.53) TSHRPPARDTP53TDP1CA12
Diethyl Hydrogen Phosphate SCHEMBL3133022 0.80 TSHR (0.53) TSHRPPARDTP53TDP1CA12
Diethyl Hydrogen Phosphate SCHEMBL4948463 0.80 TSHR (0.53) TSHRPPARDTP53TDP1CA12
Diethyl Hydrogen Phosphate SCHEMBL6694735 0.80 TSHR (0.53) TSHRPPARDTP53TDP1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101917848-B S-alkylisothiouronium derivatives for the treatment of uterine hypercontractility disorders BARKAN FARMA S R L 2014-02-12 CN claimed
CN-101917848-A S-alkylisothiouronium derivatives for the treatment of uterine hypercontractility disorders BARKAN FARMA S R L 2010-12-15 CN claimed
CN-101300003-A Prevention of hypotension and stabilization of blood pressure in hemodialysis patients MEDITOR PHARMACEUTICALS LTD (IL) 2008-11-05 CN claimed
CN-1116871-C Pharmaceutical compositions containing S-alkylisothiouronium derivatives MEDITOR PHARMACEUTICALS LTD (IL) 2003-08-06 CN claimed
CN-1234737-A Pharmaceutical compositions containing S-alkylisothiouronium derivatives MEDITOR PHARMACEUTICALS LTD (IL) 1999-11-10 CN claimed
CN-101917848-B S-alkylisothiouronium derivatives for the treatment of uterine hypercontractility disorders BARKAN FARMA S R L 2014-02-12 CN disclosed
CN-101917848-A S-alkylisothiouronium derivatives for the treatment of uterine hypercontractility disorders BARKAN FARMA S R L 2010-12-15 CN disclosed
CN-101300003-A Prevention of hypotension and stabilization of blood pressure in hemodialysis patients MEDITOR PHARMACEUTICALS LTD (IL) 2008-11-05 CN disclosed
CN-1116871-C Pharmaceutical compositions containing S-alkylisothiouronium derivatives MEDITOR PHARMACEUTICALS LTD (IL) 2003-08-06 CN disclosed
CN-1234737-A Pharmaceutical compositions containing S-alkylisothiouronium derivatives MEDITOR PHARMACEUTICALS LTD (IL) 1999-11-10 CN disclosed
EP-0928191-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING S-ALKYLISOTHIOURONIUM DERIVATIVES Meditor Pharmaceuticals Ltd. (IL) 1999-07-14 EP disclosed
WO-1998013036-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING S-ALKYLISOTHIOURONIUM DERIVATIVES MEDITOR PHARMACEUTICALS LTD. (IL) 1998-04-02 WO disclosed